A controlled, evidence-based trial of paliperidone palmitate, a long-acting injectable antipsychotic, in schizophrenia.
第一作者:
Henry A,Nasrallah
第一单位:
Department of Psychiatry, University of Cincinnati College of Medicine, OH 45267, USA. henry.nasrallah@uc.edu
作者:
主题词
成年人(Adult);抗精神病药(Antipsychotic Agents);基底神经节疾病(Basal Ganglia Diseases);人体质量指数(Body Mass Index);体重(Body Weight);病例对照研究(Case-Control Studies);剂量效应关系, 药物(Dose-Response Relationship, Drug);双盲法(Double-Blind Method);药物释放系统(Drug Delivery Systems);循证医学(Evidence-Based Medicine);女(雌)性(Female);人类(Humans);注射(Injections);异恶唑类(Isoxazoles);Kaplan-Meiers评估(Kaplan-Meier Estimate);男(雄)性(Male);中年人(Middle Aged);棕榈酸盐类(Palmitates);精神病状态评定量表(Psychiatric Status Rating Scales);精神分裂症(Schizophrenia);治疗结果(Treatment Outcome)
DOI
10.1038/npp.2010.79
PMID
20555312
发布时间
2022-04-08
- 浏览28

Neuropsychopharmacology
2072-82页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文